Language Select
Varian Logo

Notícias recentes

Março 20, 2018
Varian (NYSE: VAR) announced PTC St. Petersburg Center of Nuclear Medicine of the Sergey Berezin Medical Institute successfully completed its first pediatric patient treatment with the Varian... Read more
Março 14, 2018
Varian (NYSE: VAR) today announced it has received clearances from the U.S. antitrust authorities and the German Federal Cartel Office (FCO) on the proposed acquisition of all of the outstanding... Read more
Março 12, 2018
Varian (NYSE: VAR) today announced that it will report results for the second quarter of fiscal year 2018 after market close on Wednesday, April 25, 2018. The news release will be followed by a... Read more

Postagens recentes do blog

Fev 16, 2018 | Centerline
Researchers have reported that cervical cancer patients who are treated with combined external beam radiotherapy (EBRT) and brachytherapy appear to have a significantly better overall survival... Read more
Jan 03, 2018 | Blog Spot ON
Proton-Man symbolizes the determination and technology that doctors employ when they utilize proton therapy to fight cancer. Proton-Man's mission is to spread the word about proton therapy and... Read more
Nov 29, 2017 | Blog Spot ON
The potential benefits of proton therapy have yet to be realized. That motivated a group of us to undertake a comprehensive look at the physics and technology powering intensity-modulated proton... Read more

Receba notícias por e-mail
Assinar agora

Corporate Communications Contact

Mark Plungy
Director, Public Relations
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
[email protected]

Monica Prokocki
Director, Investor Relations
[email protected]